Myocarditis: An Interleukin-1-Mediated Disease? - Wikidata - awgldk - TriplyDB

Myocarditis: An Interleukin-1-Mediated Disease?

Myocarditis: An Interleukin-1-Mediated Disease?

http://www.wikidata.org/entity/Q55397626

about

Anakinra Therapy for Non-cancer Inflammatory Diseases

P2860

Q59136398-72D94E34-A4B9-4BC0-A029-D0CB482EB093

P2860

Myocarditis: An Interleukin-1-Mediated Disease?

http://www.wikidata.org/entity/Q55397626

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Myocarditis: An Interleukin-1-Mediated Disease?

@en

Myocarditis: An Interleukin-1-Mediated Disease?

@nl

type

label

Myocarditis: An Interleukin-1-Mediated Disease?

@en

Myocarditis: An Interleukin-1-Mediated Disease?

@nl

prefLabel

Myocarditis: An Interleukin-1-Mediated Disease?

@en

Myocarditis: An Interleukin-1-Mediated Disease?

@nl

P1433

Q55397626-0BE0640A-1F15-41FE-82E6-3F9078C24BBE

P1476

Q55397626-A4F4D957-C6B9-4760-8C76-F21FEFBF7DAD

P2093

Q55397626-1846A9E9-181A-451B-8674-7B35D0A8FA77

Q55397626-3E3F9EBA-89BE-40DE-B5C7-AE4C0AC0068A

Q55397626-A8B44071-EE1C-4F27-9370-5557A707D813

Q55397626-DACE7543-7909-4A6E-93C5-D1D65EF1F4BD

P2860

Q55397626-01266AF1-9BF1-4C3D-AE77-9DF6734E1DF8

Q55397626-028C0C20-D6BD-4165-A425-2A9098EA17D5

Q55397626-04A200A6-7D31-4B04-9526-B4517BA8091D

Q55397626-085507A0-A142-49A3-AE4E-37556B919090

Q55397626-0EF5B6BA-807A-413E-8DDD-581DB4ACE503

Q55397626-16895CCF-9E72-4FB5-8535-EDE9DDCE236D

Q55397626-197835B8-F632-461E-9330-E991DACC7A9D

Q55397626-1A0D91D5-1378-40E5-A17E-EE3D36A7CDA1

Q55397626-1A40A826-0669-47E3-BC55-60945A18F33A

Q55397626-1A43EB1E-B83C-4EE9-9CA9-5FEC29A58E1F

P304

Q55397626-087678FF-8C73-4E56-969C-208BDDDE9A6A

P31

Q55397626-C6F3C146-9634-464A-BC47-CE376D5ECAC7

P356

Q55397626-8A9E2FDE-4499-4ECA-9360-83156ED45162

P478

Q55397626-0293D7BE-DE21-42A6-8376-2EEBCC4FF0E8

P50

Q55397626-3A9722C8-8C2B-4E53-9B2A-71A43370016A

P577

Q55397626-6230649E-4A8B-4D93-8F2F-C20C292C2B5A

P698

Q55397626-25FE4A32-0039-457E-AA26-553998BA577F

P921

Q55397626-6cd57ac7-ab05-4111-a5d0-cf62d20549c3

P932

Q55397626-3A4AFF20-9133-450F-A7FE-1D0580E40E11

P356

FIMMU.2018.01335

P1433

Frontiers in Immunology

P1476

Myocarditis: An Interleukin-1-Mediated Disease?

@en

P2093

Corrado Campochiaro

http://www.w3.org/2001/XMLSchema#string

Giacomo De Luca

http://www.w3.org/2001/XMLSchema#string

Giulio Cavalli

http://www.w3.org/2001/XMLSchema#string

Moreno Tresoldi

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies

Update on myocarditis

Targeting interleukin-1 in heart disease

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the

Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure

Dilated cardiomyopathy.

Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinra

Unresolved issues in theories of autoimmune disease using myocarditis as a framework

MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.

P304

1335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01335

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29951067

http://www.w3.org/2001/XMLSchema#string

P921

P932

6008311

http://www.w3.org/2001/XMLSchema#string